Consumer Confidence Hits the Skids
The Conference Board released the reading on consumer confidence for the month of September, and the it looks like confidence hit the skids.
All Work
Chris Lange
Chicago PMI Signals Slower Business Activity
The Chicago Business Barometer for the month of September came in lower than the Bloomberg consensus estimate.
High-Yield Approaching Dangerous Levels, Will the Sell-Off Continue?
The world of high-yield bonds and high-yield products has been rocked in 2014 due to several defining factors.
Merrill Lynch Jumps Into the Aluminum Upgrade Brigade
Merrill Lynch has issued key analyst upgrades in aluminum producers Alcoa and Century Aluminum with big upside targets.
Boot Barn Files for IPO
Boot Barn Holdings Inc. filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering
Analyst Shows Why Nike Is Worth $100
Wikimedia CommonsCredit Suisse issued a research report today that Nike, Inc. (NYSE: NKE) might be worth more than previously thought. In the wake of a strong earnings report, Nike seems poised more than ever to finish…
Full Walgreen Earnings Preview
Courtesy of WalgreenWalgreen Co. (NYSE: WAG) is set to report its earnings before the market opens Tuesday. This drugstore retail giant hopes to turn around investors’ negativity after a rough month of August that…
Kimree Files for IPO: Profitable E-Cigarette Maker in China
Kimree Inc. has filed an F-1 statement with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Is Ambit Biosciences Getting Enough in Its Buyout?
Ambit Biosciences has announced that it is entering into a merger with Daiichi Sankyo in a deal worth up to $410 million.
Is BlackBerry Stock Now Fairly Priced?
Many investors remain confused about BlackBerry's turnaround hopes. It appears that analysts are struggling to find equilibrium as well.
Is TIBCO’s Buyout Fairly Valued?
TIBCO Software announced Monday morning that private equity firm Vista Equity Partners would be taking it private.
MLP Watch: Columbia Pipeline Partners Files for IPO
Columbia Pipeline Partners has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Will Analysts Start Following Alimera After Its FDA Approval?
Alimera Sciences traded up big on Monday on news that the company received FDA approval for its diabetic macular edema drug Iluvien.
Would a SoftBank and DreamWorks Merger Go Straight to DVD?
DreamWorks Animation shares surged on reports of talks with Japan’s SoftBank for a potential buyout.
Coherus Files for IPO: Biotech to Biosimilars
Coherus Biosciences Inc. filed an S-1 with the Securities and Exchange Commission for an initial public offering.
How Will the Market Treat the Yodlee IPO?
Yodlee S-1 SEC FilingYodlee Inc. filed over the summer with the Securities and Exchange Commission for an initial public offering, and now this IPO is on deck for the week ahead. The company is…
More Good News for MLPs: Goldman Sachs Fund IPO
Goldman Sachs had an initial offering Friday morning for one of its newest funds, Goldman Sachs MLP Energy Renaissance Fund.
Activision Analyst Looks Beyond Destiny Sell-Off
Following the release of Destiny, Activision Blizzard has seen its stock fall despite overall positive reviews from gamers.
Digital Ally Contract Valued at Only $200,000 — Hope for Much More
Digital Ally traded higher in the premarket hours following a $200,000 order from the U.S. military.
Is Diamond Foods Turnaround Finally Afoot?
Diamond Foods reported its earnings Thursday after the market closed, and 24/7 Wall St. is taking a look at how the 2015 guidance will value its ongoing turnaround.